Journal of the Korean Ophthalmological Society 2002;43(3):599-607.
Published online March 1, 2002.
The Neuroprotective Effect of alpha-phenyl-N-tert-butyl-nitrone (PBN) in the Argon Laser Induced Retinal Ischemia.
Hyung Kyu Park, Won Sub Son, Hyung Woo Kwak
1Department of Ophthalmology, College of Medicine, Kyung Hee University, Seoul. Korea. hwkwak@khmc.or.kr
2Dr. Son's Eye Clinic, Seoul, Korea.
아르곤레이저로 유도된 망막 허혈성 변화에 대한 PBN의 신경보호효과
박형규 ( Hyung Kyu Park ) , 손원섭 ( Won Sub Son ) , 곽형우 ( Hyung Woo Kwak )
Abstract
PURPOSE
We examined the ability of alpha-phenyl-tert-butyl-nitrone (PBN), an electron spin trapper, to determine the neuroprotective effect in the argon laser induced ischemic rat retina model. METHODS: After ischemic condition of rat retina was induced by argon green laser, PBN was given intraperitoneally at 50 or 100 mg/kg and normal saline was injected to control group. After 24 hours, 48 hours, and 7 days, the neuroprotective effect of PBN was examined by electroretinogram (ERG) and after 7 days, the enucleation of eyes was performed and histologic findings were compared by light microscopy and transmission electron microscopy. RESULTS: We found relatively reduced amplitude of ERG wave in the PBN injected group but not so greatly reduced as in normal saline control group. The retinal ganglion cell (RGC) layer and the number of RGCs were affected by acute ischemic changes but in the group of PBN treatment, the cell membrane was well preserved and vecuoles formation, cytoplasmic destructions, nuclear chromatin condensation were reduced. CONCLUSIONS: Systemic administration of PBN can ameliorate an argon laser induced retinal ischemia. Further investigations are necessary to decide effective dose without toxicity and to find more convenient methods of administrations.
Key Words: Neuroprotection;PBN;Retinal ischemia;Spin trapper


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next